INTRODUCTION
Aldehyde dehydrogenase (EC 1.2.1.3) is a homotetrameric enzyme consisting of four identical subunits. In the human liver two isoenzymes have been identified: one cytoplasmic (El) and the other mitochondrial (E2) (Greenfield & Pietruszko, 1977) . Comparison of the subunits of the two isoenzymes shows the primary structures to have 68 % positional identity (Hempel et al., 1984 (Hempel et al., , 1985 . The subunits are large (500 amino acid residues) and do not resemble any of the known dehydrogenases; even the coenzyme-binding area (Rossmann fold; Rao & Rossmann, 1973) , known to be present in dehydrogenases, cannot be identified from the primary structure.
Studies of various dehydrogenases (Boyer, 1975) show that the subunit number corresponds to the stoichiometry of coenzyme binding and to the number of active sites per molecule. Even with glyceraldehyde-3-phosphate dehydrogenase, which showed 'half-of-the-sites reactivity' (MacQuarrie & Bernhard, 1971) , the presence of four coenzyme-binding sites could be unequivocally established (Taylor et al., 1948) . With the human cytoplasmic El isoenzyme only two coenzyme-binding sites were detected (Ambroziak et al., 1989) , and two sites were also detected in the corresponding enzymes from horse and sheep liver (Eckfeldt & Yonetani, 1976; Dickinson et al., 1981; Hart & Dickinson, 1983) ; thus the number of functioning active sites appears to be half the number of subunits.
Early attempts at identification of the active site established the presence of a reactive cysteine residue in both the cytoplasmic El and the mitochondrial E2 isoenzymes (Hempel & Pietruszko, 1981) . However, failure to abolish activity completely precluded its definite assignment to the active site. Thus the location of the active site remained unknown until bromoacetophenone (2-bromo-1-phenylethanone) was carefully characterized as an affinity reagent (MacKerell et al., 1986) and used for chemical modification, where it was shown to react with Glu-268 (Abriola et al., 1987) . During chemical modification, the overall stoichiometry of inactivation was also half the number of subunits. Investigation of the specificity of the bromo["C]acetophenone reaction showed one major radioactive peptide during the h.p.l.c. gradient used for peptide mapping. This peptide was identified (Abriola et al., 1987) by purification, amino acid sequencing and comparison of the sequence obtained with the total sequence of the El isoenzyme (Hempel et al., 1984) . It was found to consist of amino acid residues being the amino acid residue with which bromoacetophenone reacted. However, preliminary calculation of the radioactivity incorporated into the Glu-268-containing peptide showed that reaction of only one molecule of bromo- [14C] acetophenone per molecule corresponded to total loss of activity 
Methods
Enzyme preparation. The El isoenzyme of human liver aldehyde dehydrogenase was purified to homogeneity by following the procedure of Hempel et al. (1982a) . Homogeneity was confirmed by isoelectric focusing, starchgel electrophoresis and specific activity. The enzyme was stored at -20°C in N2-saturated 30 mM-sodium phosphate buffer, pH 6.0, containing 1 mM-EDTA, 2 % (v/v) 2-mercaptoethanol and 25 % (v/v) glycerol. Before use, the enzyme was dialysed against eight changes of N2-saturated 30 mM-sodium phosphate buffer, pH 6.0, containing 1 mM-EDTA to remove thiols and glycerol. N2-saturated buffers were used in all experiments (except where otherwise stated) to prevent air oxidation of enzyme thiol groups. To achieve N2 saturation, buffers were first exhaustively evacuated on an aspirator at room temperature to remove dissolved air. N2 was then continuously bubbled through the buffer while it was cooled to 4°C, and the buffer was stored under N2 in a firmly capped container at 4 'C.
Determination of enzyme specific activity. Included in the standard assay mixture were 0.1 M-sodium pyrophosphate buffer, pH 9.0, 500 ,tM-NAD+, 1 mMpropionaldehyde and 1 mM-EDTA in a 3.0 ml total volume. Reactions were initiated by the addition of enzyme, and reaction rates were determined by taking tangents to steady-state portions of time progress curves. Time progress curves were measured on a Varian 635 recording spectrophotometer or a Gilford 252 updated Beckman DU spectrophotometer at 25 'C in 1 cm-lightpath cuvettes by monitoring the production of NADH at 340 nm and by using an absorption coefficient of 6.22 mM-' cm-'. Protein concentrations were determined by both 280 nm absorption (Greenfield & Pietruszko, 1977) Inactivation experiments. Experiments involving the inactivation of aldehyde dehydrogenase were performed at room temperature in N2-saturated 30 mM-sodium phosphate buffer, pH 7.0, containing 1 mM-EDTA, at an enzyme concentration of 0.05 mg/ml. The enzyme was diluted into half of the total incubation volume, the bromoacetophenone was diluted into the other half, and the two were mixed together to initiate the incubation. Controls contained no bromoacetophenone. Incubations were performed for 16-20 h to ensure that all reactions went to completion.
Stoichiometry of the reaction. The stoichiometry of the reaction was measured by incubating different molar ratios of bromo [carbonyl-'4C] acetophenone with the El isoenzyme (0.05 mg/ml) in N2-saturated 30 mM-sodium phosphate buffer, pH 7.0, containing 1 mM-EDTA and 1 mM-NAD+ for 16 h. After the incubation, the samples were concentrated in an Amicon Diaflo ultrafiltration apparatus, followed by further concentration and dialysis in a Schleicher and Schuell apparatus against six changes of N2-saturated 30 mM-sodium phosphate buffer, pH 6.0, containing 1 mM-EDTA. Samples were then centrifuged to remove precipitated protein, and the specific radioactivity was determined. Controls were carried out through the same procedure except that bromoacetophenone was omitted. Bromo[carbonyl-'4C]acetophenone incorporation was determined by counting the radioactivity of a sample of the final protein solution with Biofluor scintillation cocktail (New England Nuclear) and an Intertechnique SL30 liquid-scintillation spectrometer.
Tryptic digestion and peptide mapping. Before analysis, the samples were carboxymethylated and digested with trypsin (Hempel et al., 1982b 1000 (v/v) propan-2-ol in 60.0 min. These runs were followed up by two gradients on a Supelco LC-3DP (diphenyl-bonded) column, the first one with acetonitrile as an organic modifier Samples to be subjected to amino acid analysis were hydrolysed by the methods described in Meltzer et al. (1987) , and analysis was carried out by post-column formation of derivatives with o-phthalaldehyde (Roth, 1970 (Roth, , 1976 .
RESULTS

Reaction of bromoaceitophenone with the El isoenzyme
The El isoenzyme with a specific activity of 0.6 ,tmol/ min per mg was used in these experiments. This is the highest specific activity available from our enzyme preparations. Titration of this enzyme with NAD+ or NADH (Ambroziak et al., 1989) (Fig. 1) .
From data shown in Fig. 1 (panels A-C) it can be seen that at low stoichiometries (where activity loss occurs), the incorporation of bromo[14C]acetophenone is fairly specific in that most of the label is found in fractions 40-42, which were found to contain a peptide with Glu-268 being the reactive residue (Abriola et al., 1987) . The incorporation is, however, not completely specific and becomes less specific with increasing stoichiometry (Fig.  1 , panels D and E). At low stoichiometries incorporation of radioactive label consistently occurs into fractions 14-15, 35-37 and 54-56, in addition to the main peak.
Since these could conceivably have represented partial or other cleavage products containing the same reactive residue as the main peak peptide eluted in fractions 40-42, they were selected for identification via amino acid sequence analysis. There is also radioactivity incorporation into fractions 19-20 and fractions 29-30, which is shown consistently in Fig. I (panels A-E) . However, radioactivity incorporation into these fractions at low stoichiometries represented less than 5 % of total incorporation and could not be reproduced in subsequent experiments. Lack of reproducibility may be due to use of different lots of trypsin, which could produce different cleavage products.
Identification of the reactive residues
Fraction 55 peptide. The first attempt at purification of this peptide achieved complete separation from other, non-radioactive, species, but the low level of radioactivity detected in material from the cycles during sequencing only tentatively established the reactive residue as that in the 30th cycle. There was also a discrepancy in quantification by specific radioactivity and 254 nm absorbance of phenylthiohydantoin derivatives (Table  1) , which necessitated a second attempt. The second attempt at purification confirmed this assignment, and comparison with the primary structure allowed determination that Cys-302 was the reactive amino acid in this tryptic peptide (Table 1) . The results of sequencing of the labelled peptide in fraction 55 obtained from second purification are shown in Fig. 2 Ser-Pro-CMCys-Ile-Val-Leu-Ala-Asp-Ala-Asp-Leu-AspAsn-Ala-Val-Glu-Phe-Ala-His-His-Gly-Val-Phe-Tyr-His- Fig. 1 quantitatively account for all radioactive material present before the h.p.l.c. The percentage of radioactivity incorporated at Glu-268, however, is only 51 00 of the total recovered label in the case of lowest stoichiometry. Since recovery was almost complete, the low percentage of label incorporated at Glu-268 cannot be explained by a loss of material. As the stoichiometry of incorporation increases, the percentage due to incorporation at Glu-268 falls from 51 % to a much lower level (Table 2 and Fig. 1 ). In the case of reagent incorporated at Cys-302 (as represented by peptides eluted in fractions 35 and 55), the percentage of label increases up to a stoichiometry of total bromoacetophenone incorporation of 3.90.
Correlation of activity loss with incorporation of label at Glu-268, Cys-302 and fraction 15 In Table 3 the total stoichiometry of incorporation into the El tetramer is shown along with the activity loss and molecules of reagent incorporated at Glu-268, Cys-302 and fractions 14-15. These results show that the activity loss correlates well with incorporation of radioactivity at Glu-268. Reagent incorporation at fractions 14-15 and Cys-302 also increases with increasing prefragmentation stoichiometry, but these ratios do not correlate well with activity loss. The greatest incorporation of label at Cys-302 occurs after the activity loss is essentially complete. Label incorporation into the nonspecific fractions and fractions 14-15 increases with the increase of the stoichiometry of total incorporation. However, label incorporation at either Glu-268 or Cys-302 stops once the stoichiometry of approximately 1 per molecule is reached.
DISCUSSION
Bromoacetophenone is a bromomethyl ketone, a highly reactive compound which can form a covalent bond with any nucleophile in its vicinity. Its structure resembles that of benzaldehyde, a substrate for the enzyme, allowing it to bind specifically to the substratebinding site of the aldehyde dehydrogenase molecule. It does not normally react with a carboxy group, unless it is positioned in an extremely hydrophobic environment. Thus the reaction of bromoacetophenone with Glu-268 further supports the active-site location of that residue. In view of the above, bromoacetophenone could be confidently used as a probe for stoichiometry of inactivation of aldehyde dehydrogenase. H.p.l.c. for peptide mapping makes it possible to examine the stoichiometry of chemical modification from the 'inside' of the molecule by determination of the incorporation into specific residues.
The results of identification of the consistently occurring major radioactive peaks in the peptide maps (Fig. 1) 57.3 Table 3 . Correlation of incorporation of bromol14Clacetophenone into El isoenzyme with loss of activity
The amount of reagent (mol/mol of enzyme) incorporated into specific fractions was calculated by multiplying the fraction of radioactivity recovered in these fractions (see Table 2 ) by the stoichiometry of incorporation as determined before tryptic fragmentation (see the Materials and methods section). Variability in the amount of reagent required to produce a loss of a given amount of enzyme activity has been thoroughly discussed in MacKerell et al. (1986) . 268. This residue was previously identified in our laboratory as a super-reactive cysteine residue (Hempel & Pietruszko, 1981; Hempel et al., 1982b) , but owing to lack of total inactivation its location at the active site could not be established. Thus the results of current experiments demonstrate that Cys-302 is also located at the active site of aldehyde dehydrogenase. The incorporation of label from bromo-[14C]acetophenone during activity loss occurs primarily at two residues: Glu-268 and Cys-302. The results, presented in Table 3 , demonstrate that there is a limit to the total incorporation at either of these two residues; this limit is one molecule of bromoacetophenone per tetramer of El enzyme per either residue. Incorporation into the consistently occurring fractions 14-15 increases with the increase in overall incorporation stoichiometry, but the amount of total radioactivity incorporated into this fraction does not reach a plateau as with Cys-302 or Glu-268. The same is true about the incorporation of label into other fractions (Table 3) . Since the material in fractions 14-15 appears to be derived from the reagent (see the Results section), the possibility was considered that it might have formed during the reaction with Glu-268. However, the fact that its amount increases after the reaction with Glu-268 is complete argues against it. Also, incorporation into this fraction at low total incorporation stoichiometries, where activity loss occurs, is small in comparison to that of In view of the above, it was of interest to see whether activity loss with bromoacetophenone correlated better with incorporation at Glu-268 or Cys-302. Results shown in Table 3 (when plotted) demonstrate that activity loss correlates in a linear fashion with incorporation at Glu-268 as compared with incorporation at Cys-302 (curvilinear correlation). At low total incorporation stoichiometries, the incorporation of bromoacetophenone at Cys-302 relative to that at Glu-268 is small ( Fig. 1 and (Hempel et al., 1984 (Hempel et al., , 1985 Pickett et al., 1987; Johansson et al., 1988; Jones et al., 1988; Kok et al., 1989; Farres et al., 1988; Dunn et al., 1989) . One of these sequences was of a more distant relative (aldehyde dehydrogenase, EC 1.2.1.5) from rat hepatoma (Jones et al., 1988) , which showed only approx. 300 sequence identity with aldehyde dehydrogenase (EC 1.2.1.3). This amino acid sequence was more informative in that it was found to lack all the cysteine residues of other mammalian enzymes except for Cys-302. However, the amino acid residues around this residue were not highly conserved and in no way resembled the degree of conservation seen around activesite serine or cysteine residues in the serine proteinases and cysteine proteinases (Dayhoff et al., 1972) . The degree of conservation around Cys-302 most closely approximated that found around the aspartic acid residue of the serine proteinases, when the conservation of sequences surrounding the three critical residues in the charge-relay mechanism (serine, histidine and aspartate) was examined. On the other hand, the conservation around Glu-268 was almost absolute in that the sequence Val-Thr-Leu-Glu-Leu-Gly-Gly-Lys appeared in almost all aldehyde dehydrogenases so far sequenced. The only exception is the bovine enzyme (Farres et al., 1989) , where Leu-269 has been substituted by isoleucine.
The experiments reported here were designed to understand better the 'half-of-the-sites reactivity' of aldehyde dehydrogenase . The term 'half-of-the-sites reactivity' has been applied to a variety of enzymes (glyceraldehyde-3-phosphate dehydrogenase, in particular; Harris & Waters, 1976) , and refers to the fact that at any given time only half of the potentially active sites are catalytically active. It also refers to the fact that with some chemical modifiers the stoichiometry of inactivation is less than the number of active sites. The molecule of aldehyde dehydrogenase consists of four identical subunits and contains four identical sequences containing Glu-268. Using increasing amounts of bromoacetophenone, we attempted to determine whether specific incorporation would occur at the other potential active sites after activity loss was complete. The surprising result of this work was that reaction of reagent with only one glutamate residue occurs, with an almost total activity loss. Since it is unlikely that incorporation of 0.25 equivalent of bromoacetophenone would occur into each subunit with concomitant total activity loss, the incorporation of bromoacetophenone at Glu-268 residues of the three other subunits of the aldehyde dehydrogenase molecule most probably does not occur. It does occur at a single cysteine residue that may be located on the same or on a different subunit. This suggests a high degree of asymmetry in the tetrameric enzyme and an overall structure in which one active site is unique and different from other sites in the molecule.
